Voices
Five-Year Results Highlight the Long-Term Promise of CAR T-Cell Therapy in Aggressive Blood Cancers – Lurie Cancer Center
Lurie Cancer Center/X

Five-Year Results Highlight the Long-Term Promise of CAR T-Cell Therapy in Aggressive Blood Cancers – Lurie Cancer Center

Lurie Cancer Center shared a post on X:

“New five-year results highlight the long-term promise of CAR T Cell Therapy for patients with relapsed or refractory large B Cell Lymphoma.

Researchers found durable survival outcomes, further supporting the role of Cellular Immunotherapy in treating aggressive Blood Cancers.

‘The major focus in this area of research was to develop a T-cell that could circumvent the toxicity but still kill the malignancy,’ Leo I. Gordon, MD explains.

Read more.”

Other posts about Lurie Cancer Center on OncoDaily.

 

cancer Leo I. Gordon Lurie Cancer Center lymphoma OncoDaily Oncology